Bayer Healthcare in $97.5 million kickback settlement
Diabetic supply maker Bayer Healthcare has agreed to pay $97.5 million to settle allegations that it paid kickbacks to several diabetic suppliers and caused them to submit false Medicare claims, the U.S. Justice Department said. Bayer agreed to enter into a corporate integrity agreement—which allows companies to continue in the federal Medicare program while requiring steps to safeguard against fraudulent behavior—as part of the settlement. The settlement resolves allegations that Bayer paid 11 diabetic suppliers to convert their patients to Bayer products from competitors' products. It pertains to Medicare claims submitted by the companies from 1998 to 2007.
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Interventional Radiology No Longer a Sub-Specialty
- Acute Kidney Injury Gets New Focus
- Transforming Cancer Care
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- mHealth Tackles Readmissions
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Sharp HealthCare Leaves Pioneer ACO Program
- MA an Insurance Proving Ground for Providers
- Evidence-Based Practice and Nursing Research: Avoiding Confusion